Neonatal Phencyclidine and Social Isolation in the Rat: Effects of Clozapine on Locomotor Activity, Social Recognition, Prepulse Inhibition, and Executive Functions Deficits
Overview
Affiliations
Rationale: There is a need to develop animal models of schizophrenia-like behaviors that have both construct and predictive validity. Recently, a neonatal phencyclidine (PCP) and post-weaning social isolation dual-hit model was developed; however, its face and predictive validities need to be further investigated.
Objective: The aims of this study were to extend the characterization of the behavioral changes occurring in the neonatal PCP and post-weaning social isolation dual-hit rat model and to evaluate the effects of chronic treatment with clozapine on signs related to schizophrenia.
Methods: Male Wistar rat pups were treated with PCP (10 mg/kg s.c.) on postnatal days (PND) 7, 9, and 11. Starting from weaning, neonatal PCP-treated rat pups were socially isolated, while control saline-treated rats were group housed. At adulthood, rats were assessed using behavioral tasks evaluating locomotor activity, social recognition, prepulse inhibition, and reversal learning. Clozapine (3 mg/kg i.p.) was administered daily starting from a week before behavioral tests and until the end of the study.
Results: Neonatal PCP-treated and post-weaning social isolated (PCP-SI) rats displayed persistent and robust locomotor hyperactivity as well as social recognition impairment. The latter could not be explained by variations in the motivation to interact with a juvenile rat. Weak-to-moderate deficits in prepulse inhibition and reversal learning were also observed. Chronic treatment with clozapine attenuated the observed locomotor hyperactivity and social recognition deficits.
Conclusion: The PCP-SI model presents enduring and robust deficits (hyperactivity and social recognition impairment) associated with positive symptoms and cognitive/social deficits of schizophrenia, respectively. These deficits are normalized by chronic treatment with clozapine, thereby confirming the predictive validity of this animal model.
Li D, Pan Q, Xiao Y, Hu K Schizophrenia (Heidelb). 2024; 10(1):65.
PMID: 39039065 PMC: 11263595. DOI: 10.1038/s41537-024-00485-x.
Cale J, Chauhan E, Cleaver J, Fusciardi A, McCann S, Waters H Mol Neurobiol. 2024; 61(9):6968-6983.
PMID: 38363536 PMC: 11339149. DOI: 10.1007/s12035-024-03987-y.
Shangase K, Luvuno M, Mabandla M Brain Sci. 2023; 13(6).
PMID: 37371328 PMC: 10296399. DOI: 10.3390/brainsci13060848.